ARCHIVES

New Drug Combination Improves Survival Of Ewing’s Sarcoma, Pediatric Study Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 2 | February 28, 2003

Download PDF Visit The Full Archive

Related Articles

Sanofi Responds to Criticism From Oncologists

November 8, 2012

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

Funding Opportunities: RFA: Cancer Research Network Across Health Care Systems

September 12, 1997

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

August 9, 1985

NCI Board of Scientific Advisors also approved a new SBIR grant program for research on circulating cells in cancer detection.

March 26, 2004

DCE Board Okays Concepts For More Than $6 Million

March 13, 1987